New research has discovered that smoking and oral sex are tied to an increased risk of developing HPV-related oropharyngeal cancer, which is a form of head and neck cancer activated by exposure to the human papillomavirus (HPV).Although the risk is increased, it is still low; only 0.7 percent of men are ever likely developing oropharyngeal cancer during their lifetimes, according to the new study.The risk of developing the condition was found to be considerably lower among women, non-smokers, and those who had had fewer than five partners with whom they had performed oral sex.Prof. Gypsyamber D'Souza, of the Johns Hopkins Bloomberg School of Public Health, and Dr. Carole Fakhry, of the Johns Hopkins Department of Otolaryngology-Head and Neck Surgery — both of which are located in Baltimore, MD — conducted the research.
Their results have been published in the journal Annals of Oncology.Every year in the United States, there are approximately 16,500 cases of oropharyngeal squamous cell carcinoma, which is the most common type of oropharyngeal cancer. More than 11,500 of these are HPV-related.
More than 100 different types of HPV exist, but only a few of these are known to cause cancer. HPV16 or 18, for example, triggers most cases of cervical cancer, and HPV16 is known to cause most oropharyngeal cancers.
Experts have predicted that by 2020, the incidence of oropharyngeal cancer will overtake that of cervical cancer."For these reasons," says Prof. D'Souza, "it would be useful to be able to identify healthy people who are most at risk of developing oropharyngeal cancer in order to inform potential screening strategies, if effective screening tests could be developed."She adds, "Most people perform oral sex in their lives, and we found that oral infection with cancer-causing HPV was rare among women regardless of how many oral sex partners they had.""Among men who did not smoke," Prof. D'Souza says, "cancer-causing oral HPV was rare among everyone who had less than five oral sex partners, although the chances of having oral HPV infection did increase with number of oral sexual partners, and with smoking."The study data came from 13,089 individuals, all of whom were aged 20–69 years old, who took part in the National Health and Nutrition Examination Survey.The participants had all been tested for oral HPV infection. To predict the risk of oropharyngeal cancer from oral HPV infection, the researchers used data on oropharyngeal cancer cases and deaths from U.S. registries.
Smoking and oral sex partners elevate risk
Prof. D'Souza and Dr. Fakhry found the lowest prevalence of oral infection with cancer-causing forms of HPV in women who had had one or no oral sex partners during their lifetimes.
Of these, 1.8 percent were smokers and 0.5 percent were non-smokers. The risk of infection climbed slightly to 1.5 percent for women who had had two to more oral sex partners.
Among men, those who had had one or no oral sex partners were at the lowest risk, with a prevalence of 1.5 percent for oral HPV infection. Among men with two to four oral sex partners, prevalence increased to 4 percent among non-smokers and elevated further to 7.1 percent among men who smoked.
Non-smoking men who had had five or more oral sex partners had a prevalence of oral HPV infection of 7.4 percent. The highest prevalence of infection — reaching 15 percent — was observed among men with five or more oral sex partners and who smoked.
Continue reading.. Could oral sex raise your head and neck cancer risk? [...]
Experts have warned even a small increase in traffic fume exposure increases the chances of dying from any form of cancer by more than a fifth. Scientists believe tiny specks of soot from traffic fumes act as a Trojan horse for other toxic chemicals to ... [...]
... of side effects - and tumors could even become resistant, but the IRB Barcelona team designed a new therapy based on a peptide - the binding of several amino acids - from wasp venom for its potential use against breast cancer, writes Nature World News. [...]
Extract from the Amur cork tree, known as huáng bò (Chinese: 黄柏 or 黄檗) in China, is part of the 50 fundamental herbs that comprise Chinese herbal therapy — a proven approach to medicine that dates back to the “Recipes for 52 Ailments” manuscript ... [...]
A prostate cancer patient is taking a stand in his underwear to potentially save lives. Kurt Jewson, 44, is currently undergoing treatment for prostate cancer. Jewson says if he had insisted upon a prostate-specific antigen (PSA) test when his doctor ... [...]
The cancer type earned its name because the cancer cells within the tumors don't possess the three growth factor receptors regularly targeted during cancer treatment. And consequently other treatments tend to be ineffective. Triple negative breast ... [...]
Researchers at Flinders Medical Centre have tapped into the power of curcumin in turmeric as a possible treatment for mesothelioma. The finding is exciting because the aggressive form of cancer that is often caused by asbestos inhalation is difficult ... [...]
A new study carried out at University College London found that genetic factors and abnormalities may be detectable in breast cell DNA, allowing for an advanced 'early warning' system for breast cancer detection and the early provision of treatment. [...]
The global medical community has witnessed a rise in antibiotic-resistant "superbugs" as the use of antibiotics has increased. But now, a new study suggests that certain antibiotics are not only ineffective at treating such infections, but they can ... [...]
A single dose of a new drug could 'reboot' the immune system of patients with rheumatoid arthritis, say researchers. They have developed a protein agent modelled on the body's own natural defences to combat the inflammation that can destroy joints. [...]
Our long-term goal is to develop new metabolic-based therapeutic approaches for the detection and treatment of prostate cancer." While the bulk of work is being done at the Center for Nuclear Receptors and Cell Signaling in UH's College of Natural ... [...]
A drug used to fight breast cancer could be safe for treating type 2 diabetes and obesity, according to researchers at the University of Aberdeen. The drug, Fenretinide, inhibits the growth of several human cancer cell lines, and has been used in ... [...]